Device Trial Radar · NCT06541795
Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses
Last checked: Nov 20, 2026Latest source record: Sep 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Jun 2025
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Alcon ResearchNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 7, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this post-market study is to describe the long-term safety and performance of AcrySof IQ Vivity and AcrySof IQ Vivity Toric intraocular lens (IOL) models in a real-world setting through routine clinical practice.
Conditions
- Aphakia
- Presbyopia
- Residual Refractive Cylinder
Interventions
AcrySof IQ Vivity Extended Vision IOLDevice
UV-absorbing, with or without blue light filtering, foldable IOL implanted in the capsular bag of the eye for the visual correction of aphakia in adult patients from whom a cataractous lens has been removed. The IOL mitigates the effects of presbyopia by providing an extended depth of focus. The toric models in addition reduce residual refractive astigmatism in patients with pre-existing corneal astigmatism.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Binocular Best Corrected Distance Visual Acuity (BCDVA) at Visit 1Time frame: Visit 1, Year 3-5 postoperative
- Incidence of adverse eventsTime frame: Up to Year 3-5 postoperative
- Incidence of device deficienciesTime frame: Up to Year 3-5 postoperative
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Contact Alcon Call Center for Trial Locations
Fort Worth, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.